Ignite Creation Date:
2025-12-24 @ 3:23 PM
Ignite Modification Date:
2025-12-30 @ 12:14 PM
Study NCT ID:
NCT05000892
Status:
RECRUITING
Last Update Posted:
2022-12-02
First Post:
2021-08-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms
Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-10
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-10-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-08-09
First Submit QC Date:
None
Study First Post Date:
2021-08-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-30
Last Update Post Date:
2022-12-02
Last Update Post Date Type:
ACTUAL